Treatment of menorrhagia with intrauterine release of progesterone.
In 12 women with menorrhagia (greater than or equal to 80 ml per menstrual period) a progesterone-releasing device (Progestasert) was inserted. The women were followed by repeated measurements of the blood loss for 12 periods. The menstrual blood loss was significantly reduced after 1 month but the duration of bleeding was somewhat prolonged. Twelve months after insertion the menstrual blood loss amounted to 35% of the blood loss before the insertion. The Progestasert is a valuable treatment for menorrhagia.
D000328:Adult; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D007501:Iron / Q000097:blood; D008595:Menorrhagia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D008598:Menstruation; D008875:Middle Aged; D011374:Progesterone / Q000008:administration & dosage* / Q000627:therapeutic use
D011374:Progesterone; D007501:Iron